Home / Blog / Product Liability / Intravenous drug with contaminants recalled

Intravenous drug with contaminants recalled

Posted on October 22, 2013 3:05 pm under Product Liability

A U.S. subsidiary of a German pharmaceutical is recalling its injectable antibiotic due to possible contaminants that may cause serious health risks, a report from the U.S. Food and Drug Administration (FDA) released on Wednesday, October 15 said.

According to the notice from the FDA, foreign particles like hair, metal bits, and cotton fiber were found in a sample of Cefepime for Injection USP and Dextrose Injection USP with lot number H3A7444 made by German firm B. Braun Melsungen. Doctors are warned to stop using the recalled antibiotic, which can cause serious health problems like strokes, blood clots, and even heart attacks. The recalled drug is been widely used in U.S. hospitals, and is available from pharmacies and medical suppliers.

Patients are advised to contact the German firm if they have problems that resulted from the contaminated drug and immediately consult a doctor.

The health problems a person sustains due to defective drugs can be devastating and burdensome. At Habush Habush & Rottier S.C. ®, we know that many people in Milwaukee are harmed by dangerous drugs and fight to help them get the justice they are seeking. Call us at (414) 271-0900 today if you need help after suffering from the use of an unsafe drug.